Investigator-Initiated Studies

We are committed to supporting investigator-initiated studies (IIS) with the goal of improving patient health and quality of life by increasing the medical and scientific knowledge around our treatments. An IIS may be a clinical or non-clinical study for which Acadia provides funding, drug product or both. 

We support programs that will: 

• Contribute knowledge to the medical and scientific community
• Address unmet needs 
• Be communicated in an appropriate scientific forum, including peer-reviewed publications

Our current areas of interest are: 

• Early Intervention: Effects and/or value of early vs. late recognition, diagnosis and treatment of PD psychosis 
• Treatment:  Non-pharmacological/pharmacological treatment in the community and long term care 
• Enduring: Pimavanserin enduring/maintenance treatment 

Acadia may consider other research proposals not included in these main areas of interest. 

Examples of appropriate requestors of IIS support include, but are not limited to: 

• Healthcare providers 
• Members of the scientific community 
• Healthcare institutions 
• Colleges and universities 
• Government research institutions